The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase III, double-blind, randomized study of nivolumab (NIVO) and ipilimumab (IPI), nivo monotherapy or placebo plus transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma (HCC).
 
Bruno Sangro
Consulting or Advisory Role - Adaptimmune; AstraZeneca; Bayer; Bristol-Myers Squibb; BTG; H3 Biomedicine; Ipsen; Lilly; Merck; Roche/Genentech; Sirtex Medical
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Ipsen; Lilly; Sirtex Medical
Research Funding - Bristol-Myers Squibb (Inst); Sirtex Medical (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb; Sirtex Medical
Other Relationship - Medscape; Target Pharmasolutions
 
James J. Harding
Consulting or Advisory Role - Adaptimmune; Bristol-Myers Squibb; CytomX Therapeutics; Eisai; Exelixis; Imvax; Lilly; Merck; Zymeworks
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Debiopharm Group (Inst); Incyte (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Polaris (Inst); Yiviva (Inst); Zymeworks (Inst)
 
Matthew Johnson
Stock and Other Ownership Interests - Endoshape; FluidX
Consulting or Advisory Role - Bayer; Boston Scientific; Bristol-Myers Squibb; Eisai; Varian Medical Systems
Research Funding - Bard Medical (Inst); Boston Scientific (Inst); Cardinal Health (Inst); Cook Medical (Inst)
Expert Testimony - Argon Medical Devices
Other Relationship - Society of Interventional Radiology Foundation
 
Daniel H. Palmer
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; MSD; Nucana; Roche; Sirtex Medical
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Eisai; MSD; Nucana; Roche; Sirtex Medical
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Sirtex Medical (Inst)
 
Julien Edeline
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb; BTG; Eisai; Ipsen; MSD; Roche
Research Funding - Beigene (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche
 
Ghassan K. Abou-Alfa
Consulting or Advisory Role - Agios; AstraZeneca; Autem Medical; Bayer; BeiGene; Berry Genomics; Celgene; CytomX Therapeutics (I); Eisai; Flatiron Health; Genoscience Pharma; Gilead Sciences; Gilead Sciences; Incyte; Ipsen; LAM Therapeutics; Lilly; Loxo (I); Merck Serono; Minapharma; QED Therapeutics; RedHill Biopharma; Roche/Genentech; Silenseed (I); Sillajen; SOBI (I); TheraBionic; twoXAR; Vector Health; Yiviva
Research Funding - Agios (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); CASI Pharmaceuticals (Inst); Exelixis (Inst); Incyte (Inst); Polaris (Inst); Puma Biotechnology (Inst); QED Therapeutics (Inst)
Travel, Accommodations, Expenses - Polaris
 
Ann-Lii Cheng
Honoraria - AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; CSR Pharma; Eisai; Exelixis; F. Hoffmann LaRoche; Ipsen; IQVIA; Merck Serono; Merck Sharp & Dohme; Novartis; Nucleix; Ono Pharmaceutical; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; CSR Pharma; Eisai; Exelixis; F. Hoffmann LaRoche; Ipsen; IQVIA; Merck Serono; Merck Sharp & Dohme; Novartis; Nucleix; Ono Pharmaceutical; Roche/Genentech
Speakers' Bureau - Amgen; Bayer Yakuhin; Eisai; Novartis; Ono Pharmaceutical
Travel, Accommodations, Expenses - Bayer Yakuhin; IQVIA; Roche/Genentech
 
Thomas Decaens
Honoraria - Abbvie; AstraZeneca; Bayer; Becton Dickinson; Bristol-Myers Squibb; Eisai; Gilead Sciences; Guerbet; Ipsen; Merck; Roche; Sanofi
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Becton Dickinson; Bristol-Myers Squibb; BTG; Eisai; Gilead Sciences; Guerbet; Ipsen; Merck; Roche; Sanofi; Sirtex Medical
Research Funding - ArQule (Inst); GenoScience Pharma (Inst)
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Gilead Sciences; Ipsen; Merck; Roche
 
Anthony B. El-Khoueiry
Honoraria - Agenus; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; CytomX Therapeutics; Eisai; EMD Serono; Exelixis; Gilead Sciences; Merck; Pieris Pharmaceuticals; Roche/Genentech
Consulting or Advisory Role - Agenus; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; CytomX Therapeutics; Eisai; EMD Serono; Exelixis; Gilead Sciences; Merck; Pieris Pharmaceuticals; Roche
Research Funding - Astex Pharmaceuticals; AstraZeneca; Merck
 
Richard S. Finn
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; CStone Pharmaceuticals; Eisai; Exelixis; Genentech/Roche; Lilly; Merck; Novartis; Pfizer
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Expert Testimony - Bayer
 
Peter R. Galle
Honoraria - Adaptimmune; Bayer Schering Pharma; Bristol-Myers Squibb; Ipsen; Lilly; MSD; Roche/Genentech; Sirtex Medical
Consulting or Advisory Role - Adaptimmune; Bayer Schering Pharma; Bristol-Myers Squibb; Lilly; MSD; Roche/Genentech; Sirtex Medical
Speakers' Bureau - Bayer Schering Pharma; Ipsen; Lilly; Roche
Travel, Accommodations, Expenses - Bayer Schering Pharma; Lilly; Sirtex Medical
 
Joong-Won Park
Honoraria - Bayer; Eisai; Ipsen
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Thomas Yau
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD Oncology
Consulting or Advisory Role - Bristol-Myers Squibb
 
Damir Begic
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Yun Shen
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Jaclyn Neely
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Ashwin Reddy Sama
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Masatoshi Kudo
Honoraria - Bayer; Bristol-Myers Squibb Japan; EA Pharma; Eisai; Lilly Japan; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; MSD; Ono Pharmaceutical; Roche
Research Funding - Abbvie (Inst); EA Pharma (Inst); Eisai (Inst); Gilead Sciences (Inst); Otsuka (Inst); Sumitomo Dainippon (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)